Skip to main content Skip to journal navigation menu Skip to site footer
contact@ukscip.com
Article

Amoxicillin in the Treatment of Mastoiditis: Efficacy, Challenges, and Future Directions

Wajan Khalid ,  Manar Alzahrani ,  Ghassan Alqahtani ,  Razan Mushayt ORCID ,  Ayat Al Sinan ,  Sadeem Alsultani ,  Aryam Alenezi ORCID ,  Khawlah Alenezi ORCID ,  Lama Alanazi ORCID ,  Tahani Abdullah ,  Khadijah Abdullah ,  Mohammed Daban ,  Naif Samah ,  Modhi Farhan

    Received: 30 September 2025; Revised: 15 December 2025; Accepted: 20 January 2026; Published: 28 January 2026

    Abstract

    Mastoiditis, a serious complication of acute otitis media, primarily affects the pediatric population and requires prompt diagnosis and treatment to prevent severe complications. This review explores the pathophysiology, clinical presentation, diagnostic techniques, and therapeutic approaches for mastoiditis, focusing on the role of amoxicillin in its management. The anatomical connection between the middle ear and mastoid air cells facilitates the spread of infection, which is further influenced by inflammatory processes, bacterial biofilms, and host immune responses. Diagnosis involves a combination of clinical findings, imaging studies such as computed tomography and magnetic resonance imaging, and microbiological cultures to guide targeted antibiotic therapy. Amoxicillin remains the first-line treatment for non-resistant cases owing to its effectiveness against common pathogens, safety profile, and cost efficiency. However, the increasing prevalence of β-lactamase-producing bacteria necessitates the use of amoxicillin-clavulanate in resistant cases. Antibiotic selection should be based on local resistance patterns and patient-specific factors, such as allergies and comorbidities. Surgical interventions, including mastoidectomy, are required in advanced or refractory cases. Future research should focus on developing novel diagnostic tools, optimizing antibiotic regimens, and implementing antimicrobial stewardship programs to combat drug resistance. Global collaboration is essential for establishing standardized guidelines and improving access to high-quality care in resource-limited settings.

    Keywords

    References

    1. 1. Favre, N.; Patel, V.A.; Carr, M.M. Complications in Pediatric Acute Mastoiditis: HCUP KID Analysis. Otolaryngol. Head Neck Surg. 2021, 165, 722–730. DOI: https://doi.org/10.1177/0194599821989633
    2. 2. Schwam, Z.G.; Ferrandino, R.; Kaul, V.Z.; et al. The National Landscape of Acute Mastoiditis: Analysis of the Nationwide Readmissions Database. Otology Neurotol. 2020, 41, 1084–1093. DOI: https://doi.org/10.1097/MAO.0000000000002745
    3. 3. Alshehri, S.; Alahmari, K.A. Pediatric Acute Mastoiditis in Saudi Arabia: Demographic Insights, Clinical Profiles, and Prognostic Factors. Children 2024, 11, 402. DOI: https://doi.org/10.3390/children11040402
    4. 4. Lee, K.J.; Ryoo, I.; Choi, D.; et al. Performance of Deep Learning to Detect Mastoiditis Using Multiple Conventional Radiographs of Mastoid. PLoS One 2020, 15, e0241796. DOI: https://doi.org/10.1371/journal.pone.0241796
    5. 5. Heywood, E.G.; Stubington, T.; Chandarana, K.; et al. Complications of Acute Mastoiditis in a Paediatric Population at a UK Tertiary Centre: A Retrospective Review. Clin. Otolaryngol. 2024, 49, 264–269. DOI: https://doi.org/10.1111/coa.14128
    6. 6. Kaufmann, M.R.; Shetty, K.; Camilon, P.R.; et al. Management of Acute Complicated Mastoiditis: A Systematic Review and Meta-analysis. Pediatr. Infect. Dis. J. 2022, 41, 297–301. DOI: https://doi.org/10.1097/INF.0000000000003452
    7. 7. Samuel, O.; Saliba, W.; Stein, N.; et al. Epidemiology of Pediatric Acute Mastoiditis in Israel: A National Registry 10-Year Perspective. Laryngoscope Investig. Otolaryngol. 2022, 7, 2139–2144. DOI: https://doi.org/10.1002/lio2.948
    8. 8. Edwards, S.; Kumar, S.; Lee, S.; et al. Epidemiology and Variability in Management of Acute Mastoiditis in Children. Am. J. Otolaryngol. 2022, 43, 103520. DOI: https://doi.org/10.1016/j.amjoto.2022.103520
    9. 9. Hoberman, A.; Paradise, J.L.; Rockette, H.E.; et al. Reduced-Concentration Clavulanate for Young Children with Acute Otitis Media. Antimicrob. Agents Chemother. 2017, 61, e00238-17. DOI: https://doi.org/10.1128/AAC.00238-17
    10. 10. Busch, L.M.; Kadri, S.S. Antimicrobial Treatment Duration in Sepsis and Serious Infections. J. Infect. Dis. 2020, 222, S142–S155. DOI: https://doi.org/10.1093/infdis/jiaa247
    11. 11. Namivandi-Zangeneh, R.; Wong, E.H.H.; Boyer, C. Synthetic Antimicrobial Polymers in Combination Therapy: Tackling Antibiotic Resistance. ACS Infect. Dis. 2021, 7, 215–253. DOI: https://doi.org/10.1021/acsinfecdis.0c00635
    12. 12. Liu, C.; Hong, Q.; Chang, R.Y.K.; et al. Phage-Antibiotic Therapy as a Promising Strategy to Combat Multidrug-Resistant Infections and to Enhance Antimicrobial Efficiency. Antibiotics 2022, 11, 570. DOI: https://doi.org/10.3390/antibiotics11050570
    13. 13. Sawyer, R.G.; Claridge, J.A.; Nathens, A.B.; et al. Trial of Short-Course Antimicrobial Therapy for Intraabdominal Infection. N. Engl. J. Med. 2015, 372, 1996–2005. DOI: https://doi.org/10.1056/NEJMoa1411162
    14. 14. Hoberman, A.; Paradise, J.L.; Rockette, H.E.; et al. Treatment of Acute Otitis Media in Children under 2 Years of Age. N. Engl. J. Med. 2011, 364, 105–115. DOI: https://doi.org/10.1056/NEJMoa0912254
    15. 15. Anthonsen, K.; Høstmark, K.; Hansen, S.; et al. Acute Mastoiditis in Children: A 10-Year Retrospective and Validated Multicenter Study. Pediatr. Infect. Dis. J. 2013, 32, 436–440. DOI: https://doi.org/10.1097/INF.0b013e31828abd13
    16. 16. Tang, B.-H.; Wu, Y.-E.; Kou, C.; et al. Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Neonates and Young Infants. Antimicrob. Agents Chemother. 2019, 63, e02336-18. DOI: https://doi.org/10.1128/AAC.02336-18
    17. 17. Savage, T.J.; Kronman, M.P.; Sreedhara, S.K.; et al. Treatment Failure and Adverse Events After Amoxicillin-Clavulanate vs Amoxicillin for Pediatric Acute Sinusitis. JAMA 2023, 330, 1064–1073. DOI: https://doi.org/10.1001/jama.2023.15503
    18. 18. KuKanich, K.; Lubbers, B.; Salgado, B. Amoxicillin and Amoxicillin-Clavulanate Resistance in Urinary Escherichia coli Antibiograms of Cats and Dogs from the Midwestern United States. J. Vet. Intern. Med. 2020, 34, 227–231. DOI: https://doi.org/10.1111/jvim.15674
    19. 19. Aladeyelu, O.S.; Olaniyi, K.S.; Olojede, S.O.; et al. Temporal Bone Pneumatization: A Scoping Review on the Growth and Size of Mastoid Air Cell System with Age. PLoS One 2022, 17, e0269360. DOI: https://doi.org/10.1371/journal.pone.0269360
    20. 20. Fernández-Reyes, B.A.; Guzman-Lopez, S.; Arrambide-Garza, F.J.; et al. Middle Ear Morphology and Mastoid Pneumatisation: A Computed Tomography Study. Folia Morphol. 2025, 84, 108–116. DOI: https://doi.org/10.5603/fm.100190
    21. 21. Adışen, M.Z.; Aydoğdu, M. Comparison of Mastoid Air Cell Volume in Patients with or without a Pneumatized Articular Tubercle. Imaging Sci. Dent. 2022, 52, 27–32. DOI: https://doi.org/10.5624/isd.20210153
    22. 22. Singh, A.; Thakur, R.; Kumar, R.; et al. Grading of the Position of the Mastoid Tegmen in Human Temporal Bones—A Surgeon’s Perspective. J. Int. Adv. Otol. 2020, 16, 63–66. DOI: https://doi.org/10.5152/iao.2020.7748
    23. 23. Gülay Aslan, G.; Yagiz Aghayarov, O.; Pekçevik, Y.; et al. Comparison of Tympanometric Volume Measurement with Temporal Bone CT Findings in the Assessment of Mastoid Bone Pneumatization in Chronic Otitis Media Patients. Eur. Rev. Med. Pharmacol. Sci. 2023, 27, 6–10. DOI: https://doi.org/10.26355/eurrev_202310_34063
    24. 24. Sioshansi, P.C.; Alyono, J.C.; Blevins, N.H. Mastoid Obliteration Using Autologous Bone Dust Following Canal Wall Down Mastoidectomy. Otology Neurotol. 2021, 42, 68–75. DOI: https://doi.org/10.1097/MAO.0000000000002839
    25. 25. Chen, Y.; Hu, J.; Liu, W.; et al. The Treatment of Cholesteatomas Involving the Antrum and Mastoid Using Transcanal Underwater Endoscopic Ear Surgery. Otology Neurotol. 2020, 41, 1379–1386. DOI: https://doi.org/10.1097/MAO.0000000000002813
    26. 26. Chen, N.; Hou, Q.; Cui, Z.; et al. Effect of Otitis Media with Effusion and Its Clinical Intervention on the Development of Mastoid in Children. Acta Otolaryngol. 2014, 134, 481–484. DOI: https://doi.org/10.3109/00016489.2013.878810
    27. 27. Lampikoski, H.; Aarnisalo, A.A.; Jero, J.; et al. Mastoid Biofilm in Chronic Otitis Media. Otology Neurotol. 2012, 33, 785–788. DOI: https://doi.org/10.1097/MAO.0b013e318259533f
    28. 28. Kim, D.; Kim, S.; Kwon, Y.; et al. Structural Insights for β-Lactam Antibiotics. Biomol. Ther. 2023, 31, 141–147. DOI: https://doi.org/10.4062/biomolther.2023.008
    29. 29. Shin, E.; Nantongo, M.; Dousa, K.M.; et al. 2806. The Mechanism of β-Lactam Antibiotic Action: Structural Analysis of Mycobacterium abscessus l,d-Transpeptidases, d,d-Carboxypeptidase and Penicillin-Binding Proteins Binding by Imipenem, Ceftaroline, and Amoxicillin. Open Forum Infect. Dis. 2023, 10, ofad500.2417. DOI: https://doi.org/10.1093/ofid/ofad500.2417
    30. 30. Elsbroek, L.; Amiteye, D.; Schreiber, S.; et al. Molecular Imaging of Isolated Escherichia coli DH5α Peptidoglycan Sacculi Identifies the Mechanism of Action of Cell Wall-Inhibiting Antibiotics. ACS Chem. Biol. 2023, 18, 848–860. DOI: https://doi.org/10.1021/acschembio.2c00945
    31. 31. Koutouzis, E.I.; Michos, A.; Koutouzi, F.I.; et al. Pneumococcal Mastoiditis in Children Before and After the Introduction of Conjugate Pneumococcal Vaccines. Pediatr. Infect. Dis. J. 2016, 35, 292–296. DOI: https://doi.org/10.1097/INF.0000000000000995
    32. 32. Laakso, J.T.; Rissanen, V.; Ruotsalainen, E.; et al. Severe Acute Otitis Media and Mastoiditis Caused by Group A Beta-Hemolytic Streptococcus. Laryngoscope Investig. Otolaryngol. 2021, 6, 1158–1166. DOI: https://doi.org/10.1002/lio2.659
    33. 33. Kaur, R.; Casey, J.R.; Pichichero, M.E. Relationship with Original Pathogen in Recurrence of Acute Otitis Media after Completion of Amoxicillin/Clavulanate: Bacterial Relapse or New Pathogen. Pediatr. Infect. Dis. J. 2013, 32, 1159–1162. DOI: https://doi.org/10.1097/INF.0b013e31829e3779
    34. 34. Shiran, S.I.; Pratt, L.T.; DeRowe, A.; et al. The Clinical Value of Cranial CT Venography for Predicting Fusobacterium necrophorum as the Causative Agent in Children with Complicated Acute Mastoiditis. AJNR Am. J. Neuroradiol. 2024, 45, 761–768. DOI: https://doi.org/10.3174/ajnr.A8217
    35. 35. Anne, S.; Schwartz, S.; Ishman, S.L.; et al. Medical Versus Surgical Treatment of Pediatric Acute Mastoiditis: A Systematic Review. Laryngoscope 2019, 129, 754–760. DOI: https://doi.org/10.1002/lary.27462
    36. 36. Dharmapalan, D.; Bielicki, J.; Sharland, M. Harmonization of Amoxicillin Dose, Duration, and Formulation for Acute Childhood Respiratory Infections. Antibiotics 2023, 12, 1138. DOI: https://doi.org/10.3390/antibiotics12071138
    37. 37. Telles, J.P.; Morales, R.; Yamada, C.H.; et al. Optimization of Antimicrobial Stewardship Programs Using Therapeutic Drug Monitoring and Pharmacokinetics-Pharmacodynamics Protocols: A Cost-Benefit Review. Ther. Drug Monit. 2023, 45, 200–208. DOI: https://doi.org/10.1097/FTD.0000000000001067
    38. 38. Palmer, M.E.; Andrews, L.J.; Abbey, T.C.; et al. The Importance of Pharmacokinetics and Pharmacodynamics in Antimicrobial Drug Development and Their Influence on the Success of Agents Developed to Combat Resistant Gram Negative Pathogens: A Review. Front. Pharmacol. 2022, 13, 888079. DOI: https://doi.org/10.3389/fphar.2022.888079
    39. 39. Yang, Q.; Zhang, C.; Liu, X.; et al. The Pharmacokinetics and Pharmacodynamics of Cefquinome against Streptococcus agalactiae in a Murine Mastitis Model. PLoS One 2023, 18, e0278306. DOI: https://doi.org/10.1371/journal.pone.0278306
    40. 40. Frost, H.M.; Dominguez, S.; Parker, S.; et al. 1342. Clinical Failure Rates of Amoxicillin for the Treatment of Acute Otitis Media in Young Children. Open Forum Infect. Dis. 2020, 7, S682–S683. DOI: https://doi.org/10.1093/ofid/ofaa439.1524
    41. 41. Csonka, P.; Palmu, S.; Heikkilä, P.; et al. Outpatient Antibiotic Prescribing for 357,390 Children With Otitis Media. Pediatr. Infect. Dis. J. 2022, 41, 947–952. DOI: https://doi.org/10.1097/INF.0000000000003693
    42. 42. Choffor-Nchinda, E.; Atanga, L.C.; Nansseu, J.R.; et al. Effectiveness of Amoxicillin Alone in the Treatment of Uncomplicated Acute Otitis Media: A Systematic Review Protocol. BMJ Open 2018, 8, e021133. DOI: https://doi.org/10.1136/bmjopen-2017-021133
    43. 43. Harmes, K.M.; Blackwood, R.A.; Burrows, H.L.; et al. Otitis Media: Diagnosis and Treatment. Am. Fam. Physician 2013, 88, 435–440.
    44. 44. Dukić, S.; Matijević, S.; Daković, D.; et al. Comparison of Cefixime and Amoxicillin Plus Metronidazole in the Treatment of Chronic Periodontitis. Vojnosanit. Pregl. 2016, 73, 526–530. DOI: https://doi.org/10.2298/vsp150326133d
    45. 45. Jehan, F.; Nisar, I.; Kerai, S.; et al. Randomized Trial of Amoxicillin for Pneumonia in Pakistan. N. Engl. J. Med. 2020, 383, 24–34. DOI: https://doi.org/10.1056/NEJMoa1911998
    46. 46. Kuzucu, F.N.; Genis, C.; Sengül Emeksiz, Z.; et al. Assessment of the Safety of Alternative Antibiotics in Children with Confirmed Beta-Lactam Antibiotic Allergy. Int. Arch. Allergy Immunol. 2025, 186, 465–472. DOI: https://doi.org/10.1159/000542013
    47. 47. Rusu, A.; Munteanu, A.-C.; Arbănași, E.-M.; et al. Overview of Side-Effects of Antibacterial Fluoroquinolones: New Drugs versus Old Drugs, a Step Forward in the Safety Profile? Pharmaceutics 2023, 15, 804. DOI: https://doi.org/10.3390/pharmaceutics15030804
    48. 48. Aspinall, S.L.; Sylvain, N.P.; Zhao, X.; et al. Serious Cardiovascular Adverse Events with Fluoroquinolones versus Other Antibiotics: A Self-Controlled Case Series Analysis. Pharmacol. Res. Perspect. 2020, 8, e00664. DOI: https://doi.org/10.1002/prp2.664
    49. 49. Xiong, Y.L.; Peng, C.; Deng, Y.J.; et al. Amoxicillin-Associated Hemorrhagic Colitis: A Case Report and Literature Review. Medicine 2024, 103, e40800. DOI: https://doi.org/10.1097/MD.0000000000040800
    50. 50. Andjelić, S.; Savić, S.; Kozić, D. Amoxicillin-Clavulanate Prescribed in a Patient with Known Penicillin Allergy. Srpski Arh. Celok. Lek. 2020, 148, 493–496. DOI: https://doi.org/10.2298/SARH191222024A
    51. 51. Gómez Caballero, N.; Almenara, S.; Tévar Terol, A.; et al. Anaphylaxis Probably Induced by Transfer of Amoxicillin via Oral Sex. BMJ Case Rep. 2019, 12, e227398. DOI: https://doi.org/10.1136/bcr-2018-227398
    52. 52. Kim, S.-H.; Saide, K.; Farrell, J.; et al. Characterization of Amoxicillin- and Clavulanic Acid-Specific T Cells in Patients with Amoxicillin-Clavulanate-Induced Liver Injury. Hepatology 2015, 62, 887–899. DOI: https://doi.org/10.1002/hep.27912
    53. 53. Chaabane, N.B.; Safer, L.; Njim, L.; et al. Cholestatic Hepatitis Related to Amoxicillin. Drug Chem. Toxicol. 2011, 34, 357–358. DOI: https://doi.org/10.3109/01480545.2010.545067
    54. 54. Olesen, S.W.; Barnett, M.L.; MacFadden, D.R.; et al. The Distribution of Antibiotic Use and Its Association with Antibiotic Resistance. eLife 2018, 7, e39435. DOI: https://doi.org/10.7554/eLife.39435
    55. 55. Goebel, M.C.; Trautner, B.W.; Grigoryan, L. The Five Ds of Outpatient Antibiotic Stewardship for Urinary Tract Infections. Clin. Microbiol. Rev. 2021, 34, e00003-20. DOI: https://doi.org/10.1128/CMR.00003-20
    56. 56. Mudenda, S.; Mukosha, M.; Godman, B.; et al. Knowledge, Attitudes, and Practices of Community Pharmacy Professionals on Poultry Antibiotic Dispensing, Use, and Bacterial Antimicrobial Resistance in Zambia: Implications on Antibiotic Stewardship and WHO AWaRe Classification of Antibiotics. Antibiotics 2022, 11, 1210. DOI: https://doi.org/10.3390/antibiotics11091210
    57. 57. Charani, E.; Holmes, A. Antibiotic Stewardship—Twenty Years in the Making. Antibiotics 2019, 8, 7. DOI: https://doi.org/10.3390/antibiotics8010007
    58. 58. Abrams, E.M.; Ben-Shoshan, M. Should Testing Be Initiated Prior to Amoxicillin Challenge in Children?. Clin. Exp. Allergy 2019, 49, 1060–1066. DOI: https://doi.org/10.1111/cea.13443
    59. 59. Searns, J.B.; Stein, A.; MacBrayne, C.; et al. 1332. Single Dose Oral Amoxicillin Challenge Is a Safe and Effective Strategy to Delabel Penicillin Allergies among Low Risk Hospitalized Children. Open Forum Infect. Dis. 2020, 7, S677–S678. DOI: https://doi.org/10.1093/ofid/ofaa439.1514
    60. 60. Gervais, C.; Panetta, L.; Roy, H.; et al. 83 Success of Amoxicillin Oral Challenges in Children at Low Risk of Allergy Requiring Antibiotic in the Emergency Department. Paediatr. Child Health 2023, 28, e39. DOI: https://doi.org/10.1093/pch/pxad055.083
    61. 61. Morelo Torres, C.; Eymann, A.; Petriz, N.; et al. Diagnostic Confirmation of Amoxicillin Allergy in Children Treated at the Division of Pediatric Allergy. Arch. Argent. Pediatr. 2020, 118, 47–51. DOI: https://doi.org/10.5546/aap.2020.eng.47
    62. 62. Carter, E.J.; Zavez, K.; Rogers, S.C.; et al. Documented Penicillin Allergies on Antibiotic Selection at Pediatric Emergency Department Visits. Pediatr. Emerg. Care 2024, 40, 283–288. DOI: https://doi.org/10.1097/PEC.0000000000003023
    63. 63. Malkawi, W.A.; AlRafayah, E.; AlHazabreh, M.; et al. Formulation Challenges and Strategies to Develop Pediatric Dosage Forms. Children 2022, 9, 488. DOI: https://doi.org/10.3390/children9040488
    64. 64. Karaaslan, A.; Cetin, C.; Kole, M.T.; et al. Acute Mastoiditis in Children: A Tertiary Care Center Experience in 2015–2021. Niger. J. Clin. Pract. 2023, 26, 347–351. DOI: https://doi.org/10.4103/njcp.njcp_392_22
    65. 65. Lopes-de-Campos, D.; Pinto, R.M.; Lima, S.A.C.; et al. Delivering Amoxicillin at the Infection Site—A Rational Design through Lipid Nanoparticles. Int. J. Nanomedicine 2019, 14, 2781–2795. DOI: https://doi.org/10.2147/IJN.S193992
    66. 66. Güncüm, E.; Işıklan, N.; Anlaş, C.; et al. Development and Characterization of Polymeric-Based Nanoparticles for Sustained Release of Amoxicillin—An Antimicrobial Drug. Artif. Cells Nanomed. Biotechnol. 2018, 46, 964–973. DOI: https://doi.org/10.1080/21691401.2018.1476371
    67. 67. Torres-Figueroa, A.V.; Pérez-Martínez, C.J.; del Castillo-Castro, T.; et al. Composite Hydrogel of Poly(Acrylamide) and Starch as Potential System for Controlled Release of Amoxicillin and Inhibition of Bacterial Growth. J. Chem. 2020, 2020, 5860487. DOI: https://doi.org/10.1155/2020/5860487
    68. 68. Fujiwara, R.J.T.; Alonso, J.E.; Ishiyama, A. Temporal Trends and Regionalization of Acute Mastoiditis Management in the United States. Otology Neurotol. 2021, 42, 733–739. DOI: https://doi.org/10.1097/MAO.0000000000003050
    ×